Chronic pancreatitis fibrogenesis : the role of TGFB pathway inhibitor Smad7 in the fibrosis development
Author: Li, Xuan
Date: 2019-10-25
Location: Föreläsningssal 4X, plan 4, Alfred Nobels allé 8, Karolinska Institutet, Campus Flemingsberg
Time: 09.00
Department: Inst för klinisk vetenskap, intervention och teknik / Dept of Clinical Science, Intervention and Technology
View/ Open:
Thesis (3.082Mb)
Abstract
Chronic pancreatitis is characterized by progressive inflammation, acinar atrophy and fibrosis. Transforming growth factor-B signaling (TGFB) is the most potent fibrogenic cytokine known, and its increased expression is a common denominator for fibrosis in chronic pancreatitis. Smad7 is induced by the TGFB superfamily members as an intracellular inhibitory feedback antagonizing TGFB signaling.
To investigate the functional role of Smad7 in vivo, we induced chronic pancreatitis by repeated administration of cerulein in mice that are either ubiquitous or conditional deficient of Smad7. Mice with general deficient of Smad7 showed more severe response to chronic pancreatitis induction as indicated by a stronger accumulation of extracellular matrix (ECM), increased levels of inflammatory cells and mesenchymal cells/myofibroblasts. Mice with fibroblasts-specific deficient of Smad7 showed slightly higher fibrotic index but the production of different ECM proteins and the number of fibroblasts and inflammatory cells were not affected, although in vitro studies confirmed increased activation of mutant pancreatic stellate cells. Mice with myeloid cells-specific deficient of Smad7 exhibited fewer number of macrophages and pancreatic stellate cells and less fibronectin deposition, which might be related to the reduced capacity of Smad7 deficient macrophages to support pancreatic stellate cells’ survival. Thus, targeting TGFB signaling by Smad7 demonstrates diverse effects in different contexts, and Smad7 can exert both exacerbated and protective properties in experimental chronic pancreatitis.
Tamoxifen is widely used for the induction of CreERT-mediated genomic recombination in conditional mouse models, but it also affects the fibrotic response in several disease models. In order to investigate a possible effect of tamoxifen on pancreatic fibrogenesis and to evaluate an optimal treatment scheme in an experimental pancreatitis mouse model, we gave administered tamoxifen by oral gavage to both male and female C57BL/6J mice, and then waited for different periods of time before inducing chronic pancreatitis by cerulein. We observed a sex-specific and time-dependent effect of tamoxifen on the fibrotic response both in vivo and in vitro, and a 2-week waiting period before cerulein administration is suggested to reduce tamoxifen side effects to a minimum for the described fibrosis model in female mice.
To investigate the functional role of Smad7 in vivo, we induced chronic pancreatitis by repeated administration of cerulein in mice that are either ubiquitous or conditional deficient of Smad7. Mice with general deficient of Smad7 showed more severe response to chronic pancreatitis induction as indicated by a stronger accumulation of extracellular matrix (ECM), increased levels of inflammatory cells and mesenchymal cells/myofibroblasts. Mice with fibroblasts-specific deficient of Smad7 showed slightly higher fibrotic index but the production of different ECM proteins and the number of fibroblasts and inflammatory cells were not affected, although in vitro studies confirmed increased activation of mutant pancreatic stellate cells. Mice with myeloid cells-specific deficient of Smad7 exhibited fewer number of macrophages and pancreatic stellate cells and less fibronectin deposition, which might be related to the reduced capacity of Smad7 deficient macrophages to support pancreatic stellate cells’ survival. Thus, targeting TGFB signaling by Smad7 demonstrates diverse effects in different contexts, and Smad7 can exert both exacerbated and protective properties in experimental chronic pancreatitis.
Tamoxifen is widely used for the induction of CreERT-mediated genomic recombination in conditional mouse models, but it also affects the fibrotic response in several disease models. In order to investigate a possible effect of tamoxifen on pancreatic fibrogenesis and to evaluate an optimal treatment scheme in an experimental pancreatitis mouse model, we gave administered tamoxifen by oral gavage to both male and female C57BL/6J mice, and then waited for different periods of time before inducing chronic pancreatitis by cerulein. We observed a sex-specific and time-dependent effect of tamoxifen on the fibrotic response both in vivo and in vitro, and a 2-week waiting period before cerulein administration is suggested to reduce tamoxifen side effects to a minimum for the described fibrosis model in female mice.
List of papers:
I. Cerulein-induced pancreatic fibrosis is modulated by Smad7, the major negative regulator of transforming growth factor-β signaling. Li X, Nania S, Fejzibegovic N, Moro CF, Klopp-Schulze L, Verbeke C, Löhr JM, Heuchel RL. Biochim Biophys Acta. 2016 Sep;1862(9):1839-46.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Tamoxifen affects chronic pancreatitis-related fibrogenesis in an experimental mouse model: an effect beyond Cre-recombination. Li X, Clappier C, Kleiter I, Heuchel R. FEBS Open Bio. 2019 Aug 5.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Targeting of Smad7 in pancreatic stellate cells does not exacerbate fibrosis during chronic pancreatitis. Li X, Nania S, Kleiter I, Löhr JM, Heuchel R. [Manuscript]
IV. Macrophage-specific expression of Smad7 is required for normal inflammatory response in experimental chronic pancreatitis. Li X, Wallmann T, Nania S, Hornung L, Engelsberger V, Kleiter I, Löhr JM, Rolny C, Heuchel R. [Manuscript]
I. Cerulein-induced pancreatic fibrosis is modulated by Smad7, the major negative regulator of transforming growth factor-β signaling. Li X, Nania S, Fejzibegovic N, Moro CF, Klopp-Schulze L, Verbeke C, Löhr JM, Heuchel RL. Biochim Biophys Acta. 2016 Sep;1862(9):1839-46.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Tamoxifen affects chronic pancreatitis-related fibrogenesis in an experimental mouse model: an effect beyond Cre-recombination. Li X, Clappier C, Kleiter I, Heuchel R. FEBS Open Bio. 2019 Aug 5.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Targeting of Smad7 in pancreatic stellate cells does not exacerbate fibrosis during chronic pancreatitis. Li X, Nania S, Kleiter I, Löhr JM, Heuchel R. [Manuscript]
IV. Macrophage-specific expression of Smad7 is required for normal inflammatory response in experimental chronic pancreatitis. Li X, Wallmann T, Nania S, Hornung L, Engelsberger V, Kleiter I, Löhr JM, Rolny C, Heuchel R. [Manuscript]
Institution: Karolinska Institutet
Supervisor: Heuchel, Rainer
Co-supervisor: Löhr, Matthias; Verbeke, Caroline
Issue date: 2019-10-02
Rights:
Publication year: 2019
ISBN: 978-91-7831-578-9
Statistics
Total Visits
Views | |
---|---|
Chronic ... | 918 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Chronic ... | 33 | 23 | 29 | 20 | 25 | 26 | 11 |
File Visits
Views | |
---|---|
Thesis_Xuan_LI.pdf | 488 |
Kappa.pdf | 4 |
Kappa.pdf | 4 |
Thesis_Xuan_Li.pdf | 1 |
Thesis_Xuan_Li.pdf | 1 |
Top country views
Views | |
---|---|
United States | 187 |
China | 95 |
Sweden | 89 |
United Kingdom | 86 |
Ireland | 74 |
Germany | 59 |
Australia | 58 |
Denmark | 57 |
India | 22 |
Netherlands | 15 |
Top cities views
Views | |
---|---|
Dublin | 71 |
Sydney | 56 |
Copenhagen | 44 |
Ashburn | 41 |
Hangzhou | 30 |
Stockholm | 13 |
Mountain View | 10 |
Newcastle upon Tyne | 8 |
Bromma | 7 |
Birmingham | 6 |